How AI Will Accelerate Breakthroughs in Biotechnology with Benchling CEO Sajith Wickramasekara

How AI Will Accelerate Breakthroughs in Biotechnology with Benchling CEO Sajith Wickramasekara

Author: Conviction November 13, 2025 Duration: 48:13
Bringing new drugs to market is a costly, time-consuming endeavor. On top of that, most medicines fail at some point in the research and development phase. Sarah Guo is joined by Sajith Wickramasekara, co-founder and CEO of Benchling, a company that has not only become the central system of record for biotech R&D, but uses AI agents to assist scientists to help fix this broken system. Sajith details the roadblocks that impede drug development and approval, the “dot com” bust occurring in biotech, and how AI agents and simulation can help scientists experiment faster. Plus, they talk about China’s competitive rise in the pharma space, and the unique challenges of building an interdisciplinary culture that merges the worlds of science and software.  Rebuild biotech for the AI era - Sajith Wickramasekara Sign up for new podcasts every week. Email feedback to show@no-priors.com Follow us on Twitter: @NoPriorsPod | @Saranormous | @EladGil | @sajithw | @benchling Chapters: 00:00 – Sajith Wickramasekara Introduction 00:38 – Origin and Mission of Benchling 02:08 – The Drug Development Process 03:49 – Current State of the Biotech industry  08:46 – AI’s Role in Biotech 16:14 – Benchling AI and Its Impact 18:36 – The Future of AI in Biotech  26:28 – Debunking AI Drug Discovery Myths 28:50 – Data’s Role in Biotech 29:35 – The Importance of Tools in Pharma 31:28 – AI’s Impact on Scientific Research 34:55 – Building a Biotech Company 40:18 – Interdisciplinary Collaboration in Biotech  43:06 – Tech and Biotech: Learning from Each Other 48:16 – Conclusion

Elad Gil and Sarah Guo guide conversations in No Priors: Artificial Intelligence | Technology | Startups that cut straight to the core of what's happening now. This isn't about abstract futures; it's grounded in dialogues with the very people building and shaping the field-leading AI engineers, pioneering researchers, and the founders turning theory into reality. Each episode tackles the pressing, often daunting questions that define this technological inflection point. You'll hear them explore the practical pathways and hurdles toward AGI, debate which industries are genuinely poised for transformation, and examine how the state-of-the-art in research translates into real-world products and societal shifts. The discussions naturally span the impact on commerce, culture, and the very structure of how we live and work. Produced by Conviction, this podcast serves as an essential, clear-eyed resource for anyone looking to move beyond the hype and understand the forces driving the AI revolution. Sarah Guo, a startup investor, and Elad Gil bring their direct experience to these conversations, ensuring every interview provides substantive insight you can use.
Author: Language: English Episodes: 100

No Priors: Artificial Intelligence | Technology | Startups
Podcast Episodes
How Harvey AI is Changing the Legal Industry with Winston Weinberg [not-audio_url] [/not-audio_url]

Duration: 49:35
This week on No Priors, Sarah sits down with Harvey cofounder and CEO Winston Weinberg. Harvey is one of the leading application layer AI companies, building domain-specific AI for law firms, professional service provide…
DeepSeek, Deep Research, and 2025 Predictions with Sarah and Elad [not-audio_url] [/not-audio_url]

Duration: 22:32
This week on No Priors, Sarah and Elad celebrate the 100th episode! They dive into the biggest AI stories of 2025, breaking down DeepSeek—truth vs. hype, the rapid consumer adoption, and the real cost of training the mod…